0202 Cassava
BioCentury & Getty Images

Product Development

Big gain for Cassava on little efficacy data in Alzheimer’s

Feb 3, 2021 | 1:02 AM GMT

Cassava more than doubled its share price Tuesday on a small amount of uncontrolled data in

Read the full 383 word article

How to gain access

Continue reading with a
two-week free trial.